Evidence map›Paper›PMID 28242760›Full record

ArticleThe Journal of biological chemistry2017

DNA breaks and chromatin structural changes enhance the transcription of autoimmune regulator target genes.

Mithu Guha, Mario Saare, Julia Maslovskaja, Kai Kisand, Ingrid Liiv, Uku Haljasorg, Tõnis Tasa, Andres Metspalu, Lili Milani, Pärt Peterson

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. High-mobility group box 1 in acute kidney injury.Frontiers in pharmacology · 2025
    Review
  6. Article
  7. Thymic Mimetic Cells: Ontogeny as Immunology.Annual review of cell and developmental biology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Targeting HMGB1: A Potential Therapeutic Strategy for Chronic Kidney Disease.International journal of biological sciences · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Mithu GuhaFrom the Molecular Pathology, Institute of Biomedical and Translational Medicine.
Mario SaareFrom the Molecular Pathology, Institute of Biomedical and Translational Medicine.
Julia MaslovskajaFrom the Molecular Pathology, Institute of Biomedical and Translational Medicine.
Kai KisandFrom the Molecular Pathology, Institute of Biomedical and Translational Medicine.
Ingrid LiivFrom the Molecular Pathology, Institute of Biomedical and Translational Medicine.
Uku HaljasorgFrom the Molecular Pathology, Institute of Biomedical and Translational Medicine.
Tõnis TasaInstitute of Computer Science.
Andres MetspaluEstonian Genome Center, and.
Lili MilaniEstonian Genome Center, and.
Pärt PetersonFrom the Molecular Pathology, Institute of Biomedical and Translational Medicine, part.peterson@ut.ee.
University of Tartu · EECzech Academy of Sciences, Institute of Computer Science · CZNew York Genome Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The autoimmune regulator (AIRE) protein is the key factor in thymic negative selection of autoreactive T cells by promoting the ectopic expression of tissue-specific genes in the thymic medullary epithelium. Mutations in AIRE cause a monogenic autoimmune disease called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. AIRE has been shown to promote DNA breaks via its interaction with topoisomerase 2 (TOP2). In this study, we investigated topoisomerase-induced DNA breaks and chromatin structural alterations in conjunction with AIRE-dependent gene expression. Using RNA sequencing, we found that inhibition of TOP2 religation activity by etoposide in AIRE-expressing cells had a synergistic effect on genes with low expression levels. AIRE-mediated transcription was not only enhanced by TOP2 inhibition but also by the TOP1 inhibitor camptothecin. The transcriptional activation was associated with structural rearrangements in chromatin, notably the accumulation of γH2AX and the exchange of histone H1 with HMGB1 at AIRE target gene promoters. In addition, we found the transcriptional up-regulation to co-occur with the chromatin structural changes within the genomic cluster of carcinoembryonic antigen-like cellular adhesion molecule genes. Overall, our results suggest that the presence of AIRE can trigger molecular events leading to an altered chromatin landscape and the enhanced transcription of low-expressed genes.

Indexed as

DNA DamageTranscription, GeneticAIRE ProteinAlternative SplicingAntigens, NeoplasmCamptothecinCarcinoembryonic AntigenChromatinDNA-Binding ProteinsDNA Topoisomerases, Type IIEtoposideGene Expression ProfilingGPI-Linked ProteinsHEK293 CellsHistonesHMGB1 ProteinAIRE ProteinAntigens, NeoplasmCamptothecinCarcinoembryonic AntigenCEACAM5 protein, humanChromatinDNA-Binding ProteinsDNA Topoisomerases, Type IIEtoposideGPI-Linked ProteinsH2AX protein, humanHistonesHMGB1 ProteinHMGB1 protein, humanPoly-ADP-Ribose Binding ProteinsTOP2A protein, humanTranscription Factorsautoimmune diseasechromatin structureDNA sequencingDNA topoisomeraseimmunologyRNA splicingtolerancetranscription

Identifiers

PMID28242760
PMCPMC5399106
OpenAlexW2592582598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.